British Thoracic Society national bronchiectasis audit 2010 and 2011

Thorax

Volumn 67, Issue 10, 2012, Pages 928-930

  Hill, Adam T ^a   Welham, Sally ^b   Reid, Kerry ^b   Bucknall, C E ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b BRITISH THORACIC SOCIETY   (United Kingdom)

^c STOBHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CIPROFLOXACIN; COLISTIN; CORTICOSTEROID; GENTAMICIN; LONG ACTING DRUG; SHORT ACTING DRUG; TOBRAMYCIN;

ADULT; AGED; BRONCHIECTASIS; DISEASE EXACERBATION; ESCHERICHIA COLI; FEMALE; FORCED VITAL CAPACITY; GRAM NEGATIVE BACTERIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL SOCIETY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUCOCILIARY CLEARANCE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SHORT SURVEY; SPUTUM ANALYSIS;

EID: 84866122783     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-201983     Document Type: Article

References (1)

1. Pasteur MC, Bilton D, Hill AT; British Thoracic Society Non-CF Bronchiectasis Guideline Group. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010;65 Suppl 1:i1-58.